Literature DB >> 33176260

Autoptic findings of sudden cardiac death (SCD) in patients with arrhythmogenic ventricular cardiomiopathy (AVC) from left ventricle and biventricular involvement.

Gelsomina Mansueto1, Giuditta Benincasa2, Emanuele Capasso3, Vincenzo Graziano3, Mario Russo3, Massimo Niola3, Claudio Napoli2, Claudio Buccelli3.   

Abstract

OBJECTIVES: To evaluate autoptic histopathological findings of arrhythmogenic ventricular cardiomyopathy (AVC) as major cause of sudden cardiac death (SCD) in young adults.
BACKGROUND: According to Heart Rhythm Society (HRS)'s international consensus, histological criteria for AVC diagnosis include a progressive myocardial atrophy of the right ventricle characterized by a transmural fatty or fibrofatty replacement in a segmental or diffuse pattern (residual myocytes <60 % vs 60-75 % by morphometric analysis) explaining the electrical instability with increased risk of SCD. However, there is increasing evidence for atypical patterns of localizations and percentage of fibrofatty replacement suggesting the need to update histopathological features of AVC.
METHODS: Histology examination of ventricles, atria, and septum was performed on 10 autopsy of SCD due to AVC. Staining with hematoxylin-eosin and PicroSirius Red/Fast Green were performed on the heart samples to identify specific fibrofatty patterns.
RESULTS: Our analysis showed that: 1) myocardial replacement by a diffuse segmental fatty or fibro-fatty tissue characterized right and left ventricles as well as atrial walls; 2) the degree of fibrofatty tissue replacement was less than 40 % both in left ventricle (n = 4, 40 %) and biventricular (n = 6, 60 %) localization; 3) perivascular fibrosis, inflammatory infiltrate, areas of hypertrophy and/or areas of coagulative necrosis as signs of hypoxic damage in the first stage.
CONCLUSIONS: We confirmed prior evidence for fibrofatty replacement both in biventricular and septal localizations. Importantly, we observed a less degree (<40 %) of fibrofatty replacement as compared to current guidelines. This supports the need to further explore the histological patterns of fibrofatty infiltration in a larger study population to improve the histological diagnostic criteria of AVC.
Copyright © 2020 The Authors. Published by Elsevier GmbH.. All rights reserved.

Entities:  

Keywords:  ARVC; AVC; Arrhythmogenic right ventricular cardiomyopathy; Arrhythmogenic ventricular cardiomyopathy; Autopsy study; Fibrofatty replacement; Histology criteria; Sudden cardiac death

Year:  2020        PMID: 33176260     DOI: 10.1016/j.prp.2020.153269

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  5 in total

Review 1.  Neurological Sequelae in Patients with COVID-19: A Histopathological Perspective.

Authors:  Francesco Fisicaro; Mario Di Napoli; Aldo Liberto; Martina Fanella; Flavio Di Stasio; Manuela Pennisi; Rita Bella; Giuseppe Lanza; Gelsomina Mansueto
Journal:  Int J Environ Res Public Health       Date:  2021-02-03       Impact factor: 3.390

Review 2.  Electrocution Stigmas in Organ Damage: The Pathological Marks.

Authors:  Gelsomina Mansueto; Mario Di Napoli; Pasquale Mascolo; Anna Carfora; Pierluca Zangani; Bruno Della Pietra; Carlo Pietro Campobasso
Journal:  Diagnostics (Basel)       Date:  2021-04-10

3.  Myocardial Iron Overload in an Experimental Model of Sudden Unexpected Death in Epilepsy.

Authors:  Enes Akyuz; Zuleyha Doganyigit; Ece Eroglu; Franco Moscovicz; Amalia Merelli; Alberto Lazarowski; Jerónimo Auzmendi
Journal:  Front Neurol       Date:  2021-02-11       Impact factor: 4.003

4.  Sudden Unexpected Death Caused by Cardiac Metastasization from Histiocytic Sarcoma.

Authors:  Alessandro Feola; Paola Ciamarra; Mariavictoria De Simone; Anna Carfora; Gelsomina Mansueto; Carlo Pietro Campobasso
Journal:  Int J Environ Res Public Health       Date:  2021-12-07       Impact factor: 3.390

Review 5.  Insights Into Genetics and Pathophysiology of Arrhythmogenic Cardiomyopathy.

Authors:  Brenda Gerull; Andreas Brodehl
Journal:  Curr Heart Fail Rep       Date:  2021-09-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.